Inventor · disambiguated record
Davide Corti
Also filed as: CORTI DAVIDE
54 granted patents·26 pending applications·93 citations·filing 2005–2025
98Inventor score
Top patents by PatentIndex Score
80 records- 0198US11390664B2Antibodies that potently neutralize hepatitis B virus and uses thereofHUMABS BIOMED SA·Filed 2020·Granted Jul 19, 2022·5 cites·26 claims
- 0295US11787853B2Neutralizing anti-influenza b antibodies and uses thereofMEDIMMUNE LLC·Filed 2021·Granted Oct 17, 2023·2 cites·26 claims
- 0394US11168128B2Antibodies against SARS-CoV-2 and methods of using the sameVIR BIOTECHNOLOGY INC·Filed 2021·Granted Nov 9, 2021·12 cites·30 claims
- 0493US11174304B2Neutralizing anti-influenza B antibodies and uses thereofMEDIMMUNE LLC·Filed 2019·Granted Nov 16, 2021·5 cites·22 claims
- 0593US10683344B2Antibodies that potently neutralize hepatitis B virus and uses thereofHUMABS BIOMED SA·Filed 2016·Granted Jun 16, 2020·6 cites·18 claims
- 0692US10519221B2Neutralizing anti-influenza B antibodies and uses thereofMEDIMMUNE LLC·Filed 2019·Granted Dec 31, 2019·8 cites·21 claims
- 0791US11479599B2Antibodies against SARS-CoV-2 and methods of using the sameVIR BIOTECHNOLOGY INC·Filed 2021·Granted Oct 25, 2022·2 cites·30 claims
- 0890US10420834B2Recombinant metapneumovirus F proteins and their useUS HEALTH·Filed 2015·Granted Sep 24, 2019·4 cites·53 claims
- 0989US11059884B2Antibodies directed against Staphylococcus aureus leukotoxinsMEDIMMUNE LLC·Filed 2019·Granted Jul 13, 2021·4 cites·28 claims
- 1088US12435113B2Prefusion PIV F immunogens and their useUS HEALTH·Filed 2023·Granted Oct 7, 2025·0 cites·27 claims
- 1188US12233124B2Recombinant metapneumovirus f proteins and their useUS HEALTH·Filed 2023·Granted Feb 25, 2025·0 cites·35 claims
- 1287US12325740B2Neutralizing anti-influenza B antibodies and uses thereofMEDIMMUNE LLC·Filed 2023·Granted Jun 10, 2025·0 cites·16 claims
- 1387US11578119B2Antibodies directed against Staphylococcus aureus leukotoxinsMEDIMMUNE LLC·Filed 2021·Granted Feb 14, 2023·1 cites·20 claims
- 1487US11155606B2Antibody directed against S. aureus clumping factor a (ClfA)MEDIMMUNE LLC·Filed 2019·Granted Oct 26, 2021·3 cites·18 claims
- 1587US10494419B2Neutralizing anti-influenza A antibodies and uses thereofMEDIMMUNE LLC·Filed 2014·Granted Dec 3, 2019·9 cites·15 claims
- 1686US12492240B2Neutralizing anti-influenza A antibodies and uses thereofMEDIMMUNE LLC·Filed 2024·Granted Dec 9, 2025·0 cites·16 claims
- 1786US10329342B2Antibodies that potently neutralize RSV and uses thereofHUMABS BIOMED SA·Filed 2018·Granted Jun 25, 2019·3 cites·20 claims
- 1886US10294292B2Neutralizing anti-influenza B antibodies and uses thereofMEDIMMUNE LLC·Filed 2015·Granted May 21, 2019·4 cites·17 claims
- 1985US11117954B2Antibodies specifically binding to zika virus epitopes and uses thereofHUMABS BIOMED SA·Filed 2017·Granted Sep 14, 2021·2 cites·31 claims
- 2085US10072071B2Antibodies that neutralize RSV, MPV and PVM and uses thereofHUMABS BIOMED SA·Filed 2016·Granted Sep 11, 2018·2 cites·31 claims
- 2185US10047145B2Antibodies that potently neutralize RSV and uses thereofHUMABS BIOMED SA·Filed 2014·Granted Aug 14, 2018·5 cites·33 claims
- 2284US12304946B2Antibodies that neutralize hepatitis B virus and uses thereofHUMABS BIOMED SA·Filed 2019·Granted May 20, 2025·1 cites·28 claims
- 2384US2025263470A1Neutralizing anti-influenza b antibodies and uses thereofMEDIMMUNE LLC·Filed 2025·Application pending·0 cites
- 2483US10759847B2Antibodies that potently neutralize RSV and uses thereofHUMABS BIOMED SA·Filed 2019·Granted Sep 1, 2020·1 cites·19 claims
- 2582US11117956B2Anti-O1 antibodies and uses thereofMEDIMMUNE LLC·Filed 2017·Granted Sep 14, 2021·3 cites·25 claims
- 2682US9498531B2Antibodies that neutralize RSV, MPV and PVM and uses thereofHUMABS BIOMED SA·Filed 2013·Granted Nov 22, 2016·2 cites·26 claims
- 2781US11078239B2Prefusion PIV F immunogens and their useUS HEALTH·Filed 2017·Granted Aug 3, 2021·1 cites·24 claims
- 2880US11447542B2Anti-O2 antibodies and uses thereofMEDIMMUNE LLC·Filed 2017·Granted Sep 20, 2022·1 cites·21 claims
- 2980US2024383969A1Anti-o1 antibodies and uses thereofMEDIMMUNE LLC·Filed 2024·Application pending·0 cites
- 3079US2024352098A1ANTIBODY DIRECTED AGAINST S. AUREUS CLUMPING FACTOR A (ClfA)MEDIMMUNE LLC·Filed 2024·Application pending·0 cites
- 3178US12037381B2Antibodies that potently neutralize hepatitis B virus and uses thereofHUMABS BIOMED SA·Filed 2022·Granted Jul 16, 2024·0 cites·20 claims
- 3277US11845778B2Prefusion PIV F immunogens and their useUS HEALTH·Filed 2021·Granted Dec 19, 2023·0 cites·23 claims
- 3377US11786591B2Recombinant metapneumovirus F proteins and their useUS HEALTH·Filed 2021·Granted Oct 17, 2023·0 cites·36 claims
- 3477US2025353900A1Antibodies that neutralize hepatitis b virus and uses thereofHUMABS BIOMED SA·Filed 2025·Application pending·0 cites
- 3577US2024050565A1Antibodies that potently neutralize rabies virus and other lyssaviruses and uses thereofHUMABS BIOMED SA·Filed 2023·Application pending·0 cites
- 3676US11932682B2Neutralizing anti-influenza A antibodies and uses thereofMEDIMMUNE LLC·Filed 2021·Granted Mar 19, 2024·0 cites·20 claims
- 3776US11027007B2Recombinant metapneumovirus F proteins and their useUS HEALTH·Filed 2019·Granted Jun 8, 2021·0 cites·37 claims
- 3876US2024254207A1Multispecific antibodies specifically binding to zika virus epitopes and uses thereofHUMABS BIOMED SA·Filed 2024·Application pending·0 cites
- 3975US2025387464A1Recombinant metapneumovirus f proteins and their useTHE US SECRETARY DEPT OF HEALTH & HUMAN SERVICES·Filed 2025·Application pending·0 cites
- 4074US12312397B2Anti-O2 antibodies and uses thereofMEDIMMUNE LLC·Filed 2022·Granted May 27, 2025·0 cites·15 claims
- 4173US12018068B2Anti-O1 antibodies and uses thereofMEDIMMUNE LLC·Filed 2021·Granted Jun 25, 2024·0 cites·23 claims
- 4273US11970527B2Antibody directed against S. aureus clumping factor A (ClfA)MEDIMMUNE LLC·Filed 2021·Granted Apr 30, 2024·0 cites·15 claims
- 4373US11370829B2Antibodies that potently neutralize RSV and uses thereofHUMABS BIOMED SA·Filed 2020·Granted Jun 28, 2022·0 cites·20 claims
- 4473US2025368723A1Anti-o2 antibodies and uses thereofMEDIMMUNE LLC·Filed 2025·Application pending·0 cites
- 4572US11421020B2Antibodies that neutralize RSV, MPV and PVM and uses thereofHUMABS BIOMED SA·Filed 2020·Granted Aug 23, 2022·0 cites·20 claims
- 4671US11912757B2Antibodies specifically binding to Zika virus epitopes and uses thereofHUMABS BIOMED SA·Filed 2021·Granted Feb 27, 2024·0 cites·32 claims
- 4771US11186627B2Neutralizing anti-influenza A antibodies and uses thereofMEDIMMUNE LLC·Filed 2019·Granted Nov 30, 2021·0 cites·20 claims
- 4871US2023331821A1Antibodies against sars-cov-2 and methods of using the sameVIR BIOTECHNOLOGY INC·Filed 2022·Application pending·0 cites
- 4967US11730813B2Broadly neutralizing antibodies directed against the rabies virus glycoprotein and uses thereofHUMABS BIOMED SA·Filed 2020·Granted Aug 22, 2023·0 cites·34 claims
- 5067US11723977B2Broadly neutralizing antibodies directed against the rabies virus glycoprotein and uses thereofHUMABS BIOMED SA·Filed 2020·Granted Aug 15, 2023·0 cites·20 claims
Showing the top 50 of 80 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Davide Corti files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →